tm logo
JASERAN
Dead/Abandoned
ABANDONED - NO STATEMENT OF USE FILED

no statement of use filed

on 15 Nov 2010

Last Applicant/ Owned by

345 Park Avenue

New York

NY

10154

Serial Number

77075917 filed on 04th Jan 2007

Registration Number

N/A

Correspondent Address

Nadine P. Flynn

BRISTOL-MYERS SQUIBB COMPANY

345 Park Avenue

NEW YORK NY 10154

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

JASERAN

Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, nameRead More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies

Mark Details


Serial Number

No 77075917

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
15th Nov 2010ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
15th Nov 2010ABANDONMENT - NO USE STATEMENT FILED
23rd Mar 2010NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
22nd Mar 2010EXTENSION 4 GRANTED
16th Mar 2010TEAS EXTENSION RECEIVED
16th Mar 2010EXTENSION 4 FILED
29th Sep 2009EXTENSION 3 GRANTED
16th Sep 2009EXTENSION 3 FILED
16th Sep 2009TEAS EXTENSION RECEIVED
31st Mar 2009EXTENSION 2 GRANTED